| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.39 | 2e-14 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.28 | 4e-08 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.26 | 5e-05 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |